{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:42:11Z","timestamp":1792608131721,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:00:00Z","timestamp":1444953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:00:00Z","timestamp":1444953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12016-015-8506-7","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T04:42:14Z","timestamp":1444970534000},"page":"240-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":172,"title":["Hypereosinophilic Syndrome"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-0705","authenticated-orcid":false,"given":"Casey","family":"Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Princess","family":"Ogbogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"key":"8506_CR1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/ajh.22062","volume":"86","author":"J Gotlib","year":"2011","unstructured":"Gotlib J (2011) World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 86:678\u2013688","journal-title":"Am J Hematol"},{"key":"8506_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","volume":"54","author":"MJ Chusid","year":"1975","unstructured":"Chusid MJ, Dale CD, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54:1\u201327","journal-title":"Medicine (Baltimore)"},{"key":"8506_CR3","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jaci.2006.02.042","volume":"117","author":"AD Klion","year":"2006","unstructured":"Klion AD, Bochner BS, Gleich GJ et al (2006) Approaches to the treatment of hypereosinophilic syndromes: a workshop summary reports. J Allergy Clin Immunol 117:1292\u20131302","journal-title":"J Allergy Clin Immunol"},{"key":"8506_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","volume":"126","author":"H-U Simon","year":"2010","unstructured":"Simon H-U, Rothenburg ME, Bochner BS et al (2010) Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 126:45\u201349","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8506_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","volume":"126","author":"F Roufosse","year":"2010","unstructured":"Roufosse F, Weller PF (2010) Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 126(1):39\u201344","journal-title":"J Allergy Clin Immunol"},{"key":"8506_CR6","unstructured":"Camus P (2012) Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia). In: Pneumotox Online, the drug-induced respiratory disease website. Available at: http:\/\/www.pneumotox.com\/pattern\/view\/4\/I.c\/eosinophilic-pneumonia-pulmonary-infiltrates-and-eosinophilia\/?page=2 Accessed May 10, 2015"},{"key":"8506_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","volume":"60","author":"J Rossert","year":"2001","unstructured":"Rossert J (2001) Drug-induced acute interstitial nephritis. Kidney Int 60:804\u2013817","journal-title":"Kidney Int"},{"key":"8506_CR8","first-page":"577","volume":"14","author":"PR Criado","year":"2012","unstructured":"Criado PR, Avancini J, Santi CG et al (2012) Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses, and the immune system. Isr Med Assoc J 14:577\u2013582","journal-title":"Isr Med Assoc J"},{"key":"8506_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/bmj.2.6190.572","volume":"2","author":"GV Gill","year":"1979","unstructured":"Gill GV, Bell DR (1979) Strongyloides stercoralis in former Far East prisoners of war. Br Med J 2:572\u2013574","journal-title":"Br Med J"},{"issue":"1","key":"8506_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1128\/CMR.17.1.208-217.2004","volume":"17","author":"PB Keiser","year":"2004","unstructured":"Keiser PB, Nutman TB (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17(1):208\u2013217","journal-title":"Clin Microbiol Rev"},{"key":"8506_CR11","unstructured":"Parasites Home, Strongyloidiasis. Resources for health professionals. Centers for Disease Control and Prevention web site. http:\/\/www.cdc.gov\/parasites\/strongyloides\/health_professionals\/index.html Page last updated January 6, 2012. Page last reviewed July 19, 2013. Accessed October 23, 2014"},{"issue":"10","key":"8506_CR12","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","volume":"83","author":"PF Weller","year":"1994","unstructured":"Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83(10):2759\u20132779","journal-title":"Blood"},{"key":"8506_CR13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood.V58.5.1012.1012","volume":"58","author":"MA Flaum","year":"1981","unstructured":"Flaum MA, Schooley RT, Fauci AS et al (1981) Clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood 58:1012\u20131020","journal-title":"Blood"},{"key":"8506_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/0002-9343(91)90132-H","volume":"91","author":"MH Kaplan","year":"1991","unstructured":"Kaplan MH, Hall WM, Susin M et al (1991) Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. Am J Med 91:300\u2013309","journal-title":"Am J Med"},{"key":"8506_CR15","first-page":"627","volume":"18","author":"WB Harley","year":"1994","unstructured":"Harley WB, Blaser MJ (1994) Disseminated coccidioidomycosis associated with extreme eosinophilia. J Infect Dis 18:627\u2013629","journal-title":"J Infect Dis"},{"issue":"6","key":"8506_CR16","first-page":"589","volume":"183","author":"M Angelis","year":"1996","unstructured":"Angelis M, Yu M, Takanishi D et al (1996) Eosinophilia as a marker of adrenal insufficiency in the surgical intensive care unit. J Am Coll Surg 183(6):589\u2013596","journal-title":"J Am Coll Surg"},{"key":"8506_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.med.60.062107.090340","volume":"60","author":"A Klion","year":"2009","unstructured":"Klion A (2009) Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med 60:293\u2013306","journal-title":"Annu Rev Med"},{"issue":"9317","key":"8506_CR18","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(02)08505-7","volume":"359","author":"GJ Gleich","year":"2002","unstructured":"Gleich GJ, Leiferman KM, Padanani A et al (2002) Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 359(9317):1577\u20131578","journal-title":"Lancet"},{"key":"8506_CR19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J et al (2003) A novel tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes is a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348:1201\u20131214","journal-title":"N Engl J Med"},{"issue":"6","key":"8506_CR20","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","volume":"124","author":"PU Ogbogu","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH et al (2009) Hypereosinophilic syndromes: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 124(6):1319\u20131325","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"8506_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.leukres.2005.11.011","volume":"30","author":"A Pardanani","year":"2006","unstructured":"Pardanani A, Ketterling RP, Li C-Y et al (2006) FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leuk Res 30(8):965\u2013970","journal-title":"Leuk Res"},{"key":"8506_CR22","first-page":"68","volume-title":"World Health Organization classification of tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues","author":"BJ Bain","year":"2008","unstructured":"Bain BJ, Gilliland DG, Horny H-P et al (2008) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, or FGFR1. In: Serdlow S, Harris NL, Stein H et al (eds) World Health Organization classification of tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. IARC Press, Lyon, pp 68\u201373"},{"issue":"2","key":"8506_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4065\/mcp.2009.0503","volume":"85","author":"A Tefferi","year":"2010","unstructured":"Tefferi A, Gotlib J, Pardanani A (2010) Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 85(2):158\u2013164","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"8506_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.iac.2007.07.002","volume":"27","author":"F Roufosse","year":"2007","unstructured":"Roufosse F, Cogan E, Goldman M (2007) Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin N Am 27(3):551\u2013560","journal-title":"Immunol Allergy Clin N Am"},{"issue":"3","key":"8506_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1586\/ehm.12.14","volume":"5","author":"E Cogan","year":"2012","unstructured":"Cogan E, Roufosse F (2012) Clinical management of the hypereosinophilic syndromes. Expert Rev Hematol 5(3):275\u2013290","journal-title":"Expert Rev Hematol"},{"key":"8506_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/(SICI)1096-8628(19980319)76:3<229::AID-AJMG6>3.0.CO;2-L","volume":"76","author":"AY Lin","year":"1998","unstructured":"Lin AY, Nutman TB, Kaslow D et al (1998) Familial eosinophilia: clinical and laboratory characteristics of a U.S. kindred. Am J Med Genet 76:229\u2013237","journal-title":"Am J Med Genet"},{"key":"8506_CR27","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1086\/302053","volume":"63","author":"JD Rious","year":"1998","unstructured":"Rious JD, Stone VA, Daly MJ et al (1998) Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet 63:1086\u20131094","journal-title":"Am J Hum Genet"},{"key":"8506_CR28","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1182\/blood-2009-07-143552","volume":"114","author":"A Klion","year":"2009","unstructured":"Klion A (2009) How I treat hypereosinophilic syndromes. Blood 114:3736\u20133741","journal-title":"Blood"},{"key":"8506_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/MPG.0b013e318181b1c3","volume":"47","author":"GT Furuta","year":"2008","unstructured":"Furuta GT, Forbes D, Boey C et al (2008) Eosinophilic gastrointestinal diseases (EGIDs). J Pediatr Gastroenterol Nutr 47:234\u2013238","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"25","key":"8506_CR30","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJM198406213102501","volume":"310","author":"GJ Gleich","year":"1984","unstructured":"Gleich GJ, Schroeter AL, Marcoux JP et al (1984) Episodic angioedema associated with eosinophilia. N Engl J Med 310(25):1621\u20131626","journal-title":"N Engl J Med"},{"issue":"3","key":"8506_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3324\/haematol.2013.091264","volume":"100","author":"P Khoury","year":"2014","unstructured":"Khoury P, Herold J, Alpaugh A et al (2014) Episodic angioedema with eosinophilia (Gleich\u2019s syndrome) is a multilineage cell-cycling disorder. Haematologica 100(3):300\u2013307","journal-title":"Haematologica"},{"issue":"3","key":"8506_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","volume":"130","author":"PV Valent","year":"2012","unstructured":"Valent PV, Klion A, Horny H-P et al (2012) Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 130(3):607\u2013612.e9","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8506_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.iac.2007.07.009","volume":"27","author":"KM Leiferman","year":"2007","unstructured":"Leiferman KM, Gleich GJ, Peters MS (2007) Dermatologic manifestations of the hypereosinophilic syndromes. Immunol Allergy Clin N Am 27(3):415\u2013441","journal-title":"Immunol Allergy Clin N Am"},{"issue":"3","key":"8506_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.iac.2007.07.001","volume":"27","author":"PU Ogbogu","year":"2007","unstructured":"Ogbogu PU, Rosing DR, McDonald KH (2007) Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin N Am 27(3):457\u2013475","journal-title":"Immunol Allergy Clin N Am"},{"issue":"1","key":"8506_CR35","first-page":"1","volume":"52","author":"CJF Spry","year":"1983","unstructured":"Spry CJF, Davies J, Tai PC et al (1983) Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 52(1):1\u201322","journal-title":"Q J Med"},{"issue":"1","key":"8506_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7326\/0003-4819-102-1-109","volume":"102","author":"PM Moore","year":"1985","unstructured":"Moore PM, Harley JB, Fauci AS (1985) Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 102(1):109\u2013114","journal-title":"Ann Intern Med"},{"issue":"3","key":"8506_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.iac.2007.07.005","volume":"27","author":"ME Wechsler","year":"2007","unstructured":"Wechsler ME (2007) Pulmonary eosinophilic syndromes. Immunol Allergy Clin N Am 27(3):477\u2013492","journal-title":"Immunol Allergy Clin N Am"},{"key":"8506_CR38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","volume":"10","author":"P Khoury","year":"2014","unstructured":"Khoury P, Grayson PC, Klion AD (2014) Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol 10:474\u2013483","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"8506_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.iac.2007.06.002","volume":"27","author":"L Zuo","year":"2007","unstructured":"Zuo L, Rothenberg ME (2007) Gastrointestinal eosinophilia. Immunol Allergy Clin N Am 27(3):443\u2013455","journal-title":"Immunol Allergy Clin N Am"},{"key":"8506_CR40","first-page":"135","volume":"90","author":"JE Parrillo","year":"1977","unstructured":"Parrillo JE, Fauci AS, Wolff SM (1977) The hypereosinophilic syndrome: dramatic response to therapeutic intervention. Trans Assoc Am Phys 90:135\u2013144","journal-title":"Trans Assoc Am Phys"},{"key":"8506_CR41","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/archinte.1978.03630330044012","volume":"138","author":"RK Bush","year":"1978","unstructured":"Bush RK, Geller M, Busse WW et al (1978) Response to corticosteroids in the hypereosinophilic syndrome. Associated with increased serum IgE levels. Arch Intern Med 138:1244\u20131246","journal-title":"Arch Intern Med"},{"key":"8506_CR42","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1067\/mai.2002.127003","volume":"110","author":"A de Lavareille","year":"2002","unstructured":"de Lavareille A, Roufosse F, Schmid-Grendelmeier P et al (2002) High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. J Allergy Clin Immunol 110:476\u2013479","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8506_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/MD.0b013e31815d108c","volume":"86","author":"JJ Dahabreh","year":"2007","unstructured":"Dahabreh JJ, Giannouli S, Zoi C et al (2007) Management of hypereosinophilic syndrome: a prospective study in the era of molecular genetics. Medicine (Baltimore) 86(6):344\u2013354","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"8506_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.7326\/0003-4819-113-9-716","volume":"113","author":"RM Zielinski","year":"1990","unstructured":"Zielinski RM, Lawrence WD (1990) Interferon-alpha for the hypereosinophilic syndrome. Ann Intern Med 113(9):716\u2013718","journal-title":"Ann Intern Med"},{"issue":"9","key":"8506_CR45","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3324\/haematol.2009.010421","volume":"94","author":"F Roufosse","year":"2009","unstructured":"Roufosse F (2009) Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations. Haematologica 94(9):1188\u20131193","journal-title":"Haematologica"},{"key":"8506_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.exphem.2013.12.007","volume":"42","author":"I Sadovnik","year":"2014","unstructured":"Sadovnik I, Lierman E, Peter B et al (2014) Identification of ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA. Exp Hematol 42:282\u2013293","journal-title":"Exp Hematol"},{"key":"8506_CR47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaci.2012.07.027","volume":"130","author":"ME Wechsler","year":"2012","unstructured":"Wechsler ME, Fulkerson PC, Bochner BS et al (2012) Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol 130:563\u2013571","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"8506_CR48","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa070812","volume":"358","author":"ME Rothenberg","year":"2008","unstructured":"Rothenberg ME, Klion AD, Roufosse FE et al (2008) Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 358(12):1215\u20131228","journal-title":"N Engl J Med"},{"key":"8506_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jaci.2012.07.055","volume":"131","author":"F Roufosse","year":"2013","unstructured":"Roufosse F, Kahn J-E, Gleich GJ et al (2013) Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol 131:461\u2013467","journal-title":"J Allergy Clin Immunol"},{"key":"8506_CR50","unstructured":"GlaxoSmithKline. Compassionate use of mepolizumab in subjects with hypereosinophilic syndrome. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [4\/2014]. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT00244686: NCT00244686"},{"key":"8506_CR51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pharmthera.2012.06.005","volume":"135","author":"T Kiwamoto","year":"2012","unstructured":"Kiwamoto T, Kawasaki N, Paulson JC et al (2012) Siglec-8 as a drug able target to treat eosinophil and mast cell-associated conditions. Pharmacol Ther 135:327\u2013336","journal-title":"Pharmacol Ther"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8506-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-015-8506-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8506-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8506-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:14:37Z","timestamp":1659078877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-015-8506-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["8506"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8506-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]},"assertion":[{"value":"16 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}